VICENTE
ESTRADA PÉREZ

Profesor asociado de Ciencias de la Salud

Foto de VICENTE

Foto de Orlando Immunology Center

Orlando Immunology Center

Orlando, Estados Unidos

Publications in collaboration with researchers from Orlando Immunology Center (3)

2018

Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial
The Lancet HIV, Vol. 5, Núm. 4, pp. e162-e171

2006

Concomitant use of an active boosted protease inhibitor with enfuvirtide in treatment - Experienced, HIV-infected individuals: Recent data and consensus recommendations
HIV Clinical Trials, Vol. 7, Núm. 2, pp. 86-96
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
Lancet, Vol. 368, Núm. 9534, pp. 476-482